Hematologic Oncology

Innovative research focusing on chronic lymphocytic leukemia (CLL) treatment approaches, comparing the effectiveness of different therapeutic combinations including ibrutinib monotherapy versus combination treatments with venetoclax and obinutuzumab.

  • Treatment-naive CLL patients
  • Progression-free survival assessment
  • Novel therapy combinations

This research aims to establish optimal treatment protocols for previously untreated CLL patients.

Prostate Cancer Research

Groundbreaking studies in metastatic prostate cancer treatment, evaluating the effectiveness of ADT combined with darolutamide in patients with specific clinical characteristics.

  • Castration-naïve metastatic disease
  • Radiographic progression monitoring
  • Targeted therapy approaches

Focused on improving outcomes for vulnerable patients with newly diagnosed metastatic disease.

Advanced Prostate Cancer Therapeutics

Investigation of combination therapies for metastatic castration-resistant prostate cancer (mCRPC), examining the potential benefits of combining pembrolizumab with enzalutamide.

  • Overall survival assessment
  • Radiographic progression tracking
  • Immunotherapy combinations

Evaluating innovative treatment strategies to improve outcomes in resistant disease states.